SCHEMBL2812972

SCHEMBL2812972

COc1cc(CNc2nc3c4c(n2)N(Cc2ccccc2)CCC4NN3)cc(OC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.38
TLR7 Q9NYK1 2/20 0.38
ACHE P22303 4/20 0.37
BACE1 P56817 3/20 0.37
MCHR1 Q99705 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA2B P29275 1/20 0.35
ADORA1 P30542 1/20 0.35
MAOB P27338 2/20 0.35
HTR6 P50406 2/20 0.35
HRH1 P35367 1/20 0.34
HRH4 Q9H3N8 1/20 0.34
HTT P42858 1/20 0.34
HIF1A Q16665 1/20 0.34
MAPT P10636 1/20 0.34
SLC2A1 P11166 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2812214 0.94 ADORA2A (0.42) SIGMAR1ADORA2AADORA2BADORA1MAOB
SCHEMBL2813035 0.92 MCHR1 (0.36) SIGMAR1MCHR1MAPT
SCHEMBL537584 0.92 ACHE (0.45) SIGMAR1TLR7ACHEBACE1L3MBTL1
SCHEMBL2809448 0.89 ACHE (0.47) SIGMAR1TLR7ACHEBACE1MEN1
SCHEMBL2811945 0.88 ACHE (0.38) ACHEBACE1MEN1KMT2AHRH1
SCHEMBL2811115 0.88 MAPT (0.40) SIGMAR1ADORA2AADORA2BADORA1MAOB
SCHEMBL2816684 0.88 ACHE (0.47) SIGMAR1TLR7ACHEBACE1
SCHEMBL2813941 0.86 ADORA3 (0.41) SIGMAR1TLR7ACHEBACE1MEN1
SCHEMBL2810273 0.86 ADORA3 (0.41) SIGMAR1TLR7ACHEBACE1MEN1
SCHEMBL2813066 0.85 ACHE (0.38) TLR7ACHEBACE1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 SIGMAR1 4535/4885TLR7 3602/4885ACHE 4402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.